Texas Appeals Court Denies Novartis Petition to Halt Medicaid Fraud Qui Tam Case

The Fifteenth Court of Appeals in Texas denied Novartis Pharmaceuticals' request for mandamus relief to halt a Medicaid qui tam action brought under the Texas Medicaid Fraud Prevention Act (TMFPA). While the court acknowledged "weighty" constitutional questions raised by Novartis regarding the TMFPA's qui tam provisions, it ruled that these challenges must be addressed through ordinary appellate review rather than through extraordinary mandamus relief. The decision allows the underlying fraud case to proceed. The ruling affirms that constitutional challenges to state Medicaid fraud statutes, even when substantial, do not automatically warrant immediate appellate intervention before trial court resolution.

Managed Care